Without Graphite, There Would Be ZERO EV Batteries!
Investors constantly hear that lithium is the key to powering the transition to green energy. Truth is, today's EV batteries contain more graphite in volume than any other essential ingredients.
See This Special Report to Get the Full Story
Andrew Hykes net worth and biography

Andrew Hykes Biography and Net Worth

Drew is a proven medical device operating executive with broad functional, geographic and sector experience. From 2012-2016 Drew served as the VP of Commercial Operations at Sequent Medical where he led the commercialization strategy for the WEB Aneurysm Embolization system from early prototype to broad adoption in the European market. Sequent was acquired by Terumo Corporation in July 2016 for $380 million. Prior to Sequent, Drew spent 11 years at Medtronic. His roles at Medtronic included the VP of Marketing for the AF Solutions business, VP of Clinical and Regulatory for the AF Solutions business and Director of Investor Relations. Drew also spent three years on an expatriate assignment in Europe leading the launch of Medtronic’s first drug eluting coronary stent. Prior to Medtronic, he spent four years at ABN AMRO bank in Chicago focused on healthcare transactions. He earned a B.B.A. in Finance from the University of Wisconsin and an MBA from Harvard Business School.

What is Andrew Hykes' net worth?

The estimated net worth of Andrew Hykes is at least $8.24 million as of November 21st, 2022. Mr. Hykes owns 111,998 shares of Inari Medical stock worth more than $8,240,813 as of November 30th. This net worth evaluation does not reflect any other investments that Mr. Hykes may own. Additionally, Mr. Hykes receives an annual salary of $750,840.00 as COO at Inari Medical. Learn More about Andrew Hykes' net worth.

How old is Andrew Hykes?

Mr. Hykes is currently 49 years old. There are 3 older executives and no younger executives at Inari Medical. The oldest executive at Inari Medical is Mr. Mitchell C. Hill, Chief Financial Officer, who is 63 years old. Learn More on Andrew Hykes' age.

What is Andrew Hykes' salary?

As the COO of Inari Medical, Inc., Mr. Hykes earned a total compensation package of $829,196.00 in 2020. Mr. Hykes earned a salary of $383,782.00, a bonus of $337,500.00, options awards of $107,914.00, and no other miscellaneous compensation. There are 2 executives that earn more than Mr. Hykes. The highest earning executive at Inari Medical is Mr. William H. Hoffman, CEO, Pres & Director, who commands a salary of $1,350,000.00 per year. Learn More on Andrew Hykes' salary.

How do I contact Andrew Hykes?

The corporate mailing address for Mr. Hykes and other Inari Medical executives is 9 Parker Suite 100, Irvine CA, 92618. Inari Medical can also be reached via phone at 877-923-4747 and via email at [email protected] Learn More on Andrew Hykes' contact information.

Has Andrew Hykes been buying or selling shares of Inari Medical?

In the last ninety days, Andrew Hykes has sold $1,349,910.00 of Inari Medical stock. Most recently, Andrew Hykes sold 9,000 shares of the business's stock in a transaction on Monday, November 21st. The shares were sold at an average price of $77.66, for a transaction totalling $698,940.00. Following the completion of the sale, the chief operating officer now directly owns 111,998 shares of the company's stock, valued at $8,697,764.68. Learn More on Andrew Hykes' trading history.

Who are Inari Medical's active insiders?

Inari Medical's insider roster includes Mitch Hill (CFO), William Hoffman (CEO), Andrew Hykes (COO), Donald Milder (Director), Kirk Nielsen (Director), and Thomas Tu (Insider). Learn More on Inari Medical's active insiders.

Are insiders buying or selling shares of Inari Medical?

In the last year, insiders at the sold shares 48 times. They sold a total of 717,845 shares worth more than $56,819,968.51. The most recent insider tranaction occured on November, 28th when insider Thomas Tu sold 10,000 shares worth more than $748,600.00. Insiders at Inari Medical own 11.9 % of the company. Learn More about insider trades at Inari Medical.

Information on this page was last updated on 11/28/2022.

Andrew Hykes Insider Trading History at Inari Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/21/2022Sell9,000$77.66$698,940.00111,998View SEC Filing Icon  
10/20/2022Sell9,000$72.33$650,970.00120,998View SEC Filing Icon  
9/6/2022Sell5,000$70.00$350,000.00130,991View SEC Filing Icon  
8/1/2022Sell5,000$78.67$393,350.00135,991View SEC Filing Icon  
7/5/2022Sell5,000$70.31$351,550.00140,991View SEC Filing Icon  
6/7/2022Sell5,000$70.08$350,400.00146,984View SEC Filing Icon  
2/28/2022Sell6,304$90.05$567,675.20View SEC Filing Icon  
1/18/2022Sell5,000$76.65$383,250.00View SEC Filing Icon  
10/19/2021Sell9,000$87.76$789,840.00View SEC Filing Icon  
9/17/2021Sell9,000$80.75$726,750.00170,975View SEC Filing Icon  
8/19/2021Sell9,000$72.66$653,940.00View SEC Filing Icon  
7/19/2021Sell9,000$85.21$766,890.00View SEC Filing Icon  
6/21/2021Sell1,001$91.41$91,501.41204,711View SEC Filing Icon  
6/18/2021Sell7,999$92.29$738,227.71204,711View SEC Filing Icon  
5/19/2021Sell9,000$82.77$744,930.00203,111View SEC Filing Icon  
4/19/2021Sell9,000$103.18$928,620.00212,297View SEC Filing Icon  
3/19/2021Sell9,000$109.24$983,160.00221,571View SEC Filing Icon  
2/19/2021Sell9,000$117.74$1,059,660.00211,971View SEC Filing Icon  
1/19/2021Sell9,000$96.68$870,120.00204,641View SEC Filing Icon  
1/13/2021Sell27,600$95.04$2,623,104.00224,496View SEC Filing Icon  
1/5/2021Sell27,600$79.63$2,197,788.00253,655View SEC Filing Icon  
12/18/2020Sell27,400$70.85$1,941,290.00283,372View SEC Filing Icon  
11/30/2020Sell27,400$67.72$1,855,528.00313,541View SEC Filing Icon  
See Full Table

Andrew Hykes Buying and Selling Activity at Inari Medical

This chart shows Andrew Hykes's buying and selling at Inari Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Inari Medical Company Overview

Inari Medical logo
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Read More

Today's Range

Now: $74.47
Low: $73.30
High: $75.32

50 Day Range

MA: $74.14
Low: $65.58
High: $83.62

2 Week Range

Now: $74.47
Low: $50.50
High: $100.00


2,447 shs

Average Volume

593,259 shs

Market Capitalization

$4.00 billion

P/E Ratio


Dividend Yield



Without Graphite, There Would Be ZERO EV Batteries!
Investors constantly hear that lithium is the key to powering the transition to green energy. Truth is, today's EV batteries contain more graphite in volume than any other essential ingredients.
See This Special Report to Get the Full Story